Company Profile
Scientia Vascular is a US-based manufacturer of microfabricated neurovascular access devices, headquartered in West Valley City, Utah, USA. Founded in 2007 by John Lippert, the company operates as an independent private entity pending acquisition by Medtronic plc, serving global neurointerventional markets with a portfolio of guidewires, microcatheters, and aspiration catheters.
Core Products ＆ Technologies
Microfabricated Guidewires
• Aristotle 14 Guidewire: 0.014" microfabricated guidewire for neuro and peripheral vasculature, available in soft and standard stiffness profiles
• Aristotle 18 Guidewire: 0.018" guidewire with soft, standard, and support profiles for enhanced pushability
• Aristotle 24 Guidewire: 0.024" guidewire designed for stroke access and large-bore catheter support
• Aristotle Colossus Guidewire: 0.035" high-torque guidewire for peripheral and neurovascular navigation
• Zoom Wire 14 Guidewire: 0.014" support and extra-support profiles for complex lesion crossing
Neurovascular Catheters
• Plato 17 Microcatheter: DMSO-compatible microfabricated microcatheter for delivery of embolic coils, stents, and liquid embolics
• Socrates 38 Aspiration Catheter: Microfabricated aspiration catheter engineered for acute ischemic stroke revascularization
Market Position ＆ Certifications
Scientia Vascular holds an emerging leadership position in the global neurovascular access devices market, competing with Penumbra and Boston Scientific. Key strengths include:
• 19 years of US engineering heritage in microfabrication and nitinol alloy processing
• Proprietary microfabrication: Etched nitinol tube technology forming rings and interconnected beams for unmatched torque transmission and navigability
• Regulatory compliance: FDA 510(k) cleared guidewire portfolio (K243938, April 1, 2025); Plato 17 and Socrates 38 catheters FDA cleared (May 2024)
• Integrated portfolio: Access and treatment devices designed for efficiency when used together in hemorrhagic and acute ischemic stroke procedures
Corporate Timeline
2007 — Founded in Reno, Nevada, USA, by John Lippert
2013 — Relocated headquarters to Salt Lake City / West Valley City, Utah
2018 — Received first FDA clearance for microfabricated guidewire
2021 — Closed $50M growth equity financing led by Vivo Capital
2024 — Completed $14M growth financing led by Piper Sandler Merchant Banking; FDA cleared Plato 17 and Socrates 38 catheters
2025 — Received FDA 510(k) clearance for updated Aristotle and Zoom Wire guidewire portfolio (K243938)
2026 — Medtronic announced $550M acquisition agreement (March); awaiting FTC and international regulatory clearances, expected close in first half of FY2027
Target Markets ＆ Applications
• Acute Ischemic Stroke: Socrates 38 aspiration catheter and Aristotle guidewires for thrombectomy access and clot retrieval
• Brain Aneurysm Embolization: Plato 17 microcatheter for delivery of coils, flow diverters, and liquid embolic agents
• Neurovascular Access: Full-spectrum guidewire portfolio enabling navigation through tortuous cerebral vasculature
Contact Information
Global Headquarters
Address: 2460 South 3270 West, West Valley City, UT 84119, USA
Telephone: (888) 385-9016
Email: info@scientiavascular.com
Parent Company (Pending Acquisition)
Medtronic plc
Address: Galway, Ireland / Minneapolis, Minnesota, USA
Stock: NYSE: MDT
Website: medtronic.com
Investor Relations: investor.medtronic.com
